US Edition
WisBusiness: SHINE Technologies has a “definite plan” for doubling production of its nuclear medicine product Ilumira in Janesville as it scales to meet customer demand - Wisconsin Technology Council
Summary by wisconsintechnologycouncil.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
WisBusiness: SHINE Technologies has a “definite plan” for doubling production of its nuclear medicine product Ilumira in Janesville as it scales to meet customer demand - Wisconsin Technology Council
That’s according to CEO and founder Greg Piefer, who recently discussed the company’s path forward about a year after first launching Ilumira for targeted cancer treatment. SHINE currently has capacity to produce 100,000 doses per year, and Piefer said that could be boosted to 200,000 doses per year over time. “We’ve laid all the plans to be
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
